Trending Now

LF Dealmakers Panel: Ask the Experts: An Insider’s Approach to Getting the Best Deal

LF Dealmakers Panel: Ask the Experts: An Insider’s Approach to Getting the Best Deal

Ted Farrell, Founder of Litigation Funding Advisors moderated a panel which included Fred Fabricant, Managing Partner of Fabricant LLP, Molly Pease, Managing Director of Curiam Capital, and Boris Ziser, Partner at Schulte Roth and Zabel. The topics covered in this panel discussion were:
  • Getting up to speed on funding & insurance products
  • How to fast track diligence and deal with exclusivity
  • Negotiating key terms and spotting red flags
  • Benchmarking numbers & making the waterfall work for you
The topic of insurance came up first. Molly Pease began the discussion by noting that it isn’t always the case that funders are looking to lower risk in every situation. “It’s not always the case that we’re looking to minimize risk with insurance, because that comes with a cost,” Pease noted. “We don’t necessarily want to cut into our return, so there has to be a good fit for the insurance product.” The moderator, Ted Farrell then pointed out that starting a litigation funder isn’t exactly about lowering risk.  So, risk mitigation is important, but not the primary driver of investment decision making. Boris Ziser agreed, yet noted how insurance opens the door to lot of other investors.  “More than half of our mass tort deals have insurance,” said Ziser, “with either the entire deal or a tranche of deals being insured.” Getting wrapped by a single A-rated carrier allows certain investors to participate in the investment. On the issue of judgement preservation in the IP space, Fred Fabricant explains that in the patent space, he hasn’t seen a lot of insurance products in the pre-judgement section of the case. “There are too many uncertainties, and it is very hard to assess the risk in this phase of the case.”  Fabricant is looking forward to insurance products in this phase. “In post-judgement, much easier for insurance to assess the risk, because you’ve eliminated lots of uncertainties.”  For his part, Fabricant is interested in insurance products to mitigate risk, especially in portfolio funding cases, though he hasn’t had much experience with insurance products yet. Further topics discussed included exclusivity (Fred Fabricant noted he doesn’t shop deals between funders, in order to maintain long term relationships), funder communication with clients (funders want to move just as quickly or even more quickly than lawyers and claimants—the process can be slow sometimes if claimants need to vet whether the terms are appropriate), and funder due diligence (it’s always better to be upfront about the risks of a case, since the funder will find those out eventually anyway—and every case has risks, no sense in pretending you have a panacea of a legal claim). In the end, it was an expansive panel discussion that covered a range of topics pertinent to securing a litigation funding deal.

Commercial

View All

Litigation Capital Management Secures Further Covenant Waiver Extension

Litigation Capital Management has obtained another short extension of the covenant waiver on its debt facility with Northleaf Capital Partners, moving the expiry date from 13 November 2026 to 27 November 2026.

As reported by Investegate, the AIM-quoted funder disclosed the extension in a regulatory announcement released on 16 November 2026. Interest on the loan remains increased by 2.00% per annum for the duration of the extension, and no additional one-time waiver fee is payable.

The move continues a sequence of short-dated waivers the company has disclosed through the second half of 2026. Earlier extensions carried the waiver to the end of September and then to 13 November, with each announcement arriving close to the preceding deadline.

Covenant waivers give a borrower temporary relief from financial tests attached to a facility. For a litigation funder, cash flows depend on the timing of case resolutions, which cannot be scheduled with precision, so covenant headroom is closely linked to the pace at which concluded matters convert into cash.

Litigation Capital Management has not disclosed further detail on the facility or on the discussions behind the extension. The current waiver runs to 27 November 2026.

UK Campaign to Ban “No Win, No Fee” Advertising Also Seeks Funder Regulation

A new UK campaign calling for a ban on "no win, no fee" advertising has coupled that demand with a call for statutory regulation of litigation funding, placing the funding industry alongside claims advertising as a consumer protection concern.

As reported by Legal Futures, the campaign was launched by Fair Civil Justice with a film screened in Parliament. The group is led by executive director Seema Kennedy, a former Conservative MP. It is pressing three demands: a ban on the term "no win, no fee" in advertising for consumer claims by law firms and claims management companies; statutory regulation of litigation funding; and clear information on costs before a consumer agrees to pursue a claim.

Kennedy said the Civil Justice Council's June 2025 report, which recommended "light touch" regulation of the funding sector, could serve "as a blueprint." The Ministry of Justice indicated in January 2026 that it would introduce a framework along those lines.

The campaign cites Solicitors Regulation Authority research published in July 2026 finding that only 21% of consumers learned the potential costs of a claim before signing. It also points to the collapse of SSB Law, after which homeowners faced legal bills of up to £70,000. Fair Civil Justice counts the British and US Chambers of Commerce among its members, and the SSB Law Victims Group and Divorce Without Debt among supporting groups. Labour MP for Burnley Oliver Ryan is also involved, with the campaign referencing the roles of the SRA and the Legal Services Board.

The Consumer Legal Association opposed the campaign, saying it ignores regulatory failures and would restrict access to justice.

Woodsford’s David Haughan Warns Funder Regulation Could Cut Competition and Raise Pricing

A senior Woodsford executive has set out how the funder picks cases, where he sees growth, and why he is wary of statutory regulation of UK litigation funding.

In an interview published by Hogan Lovells Cadwalader, conducted by Valerie Kenyon and Olivier Swain, David Haughan, senior investment officer at Woodsford, said the firm has focused on group claims since around 2019. Its core UK work is in Competition Appeal Tribunal claims and shareholder actions under sections 90 and 90A of FSMA, alongside class actions in Australia, New Zealand, Canada and the Netherlands. Woodsford also now offers services on cases it does not fund, including bookbuilding for securities claims.

On case selection, Haughan said the firm declines quickly in unfamiliar jurisdictions or where a defendant could not realistically pay, adding that "the merits of the claim are by far the most important factor."

He cautioned that "the most likely consequence of a regulatory regime is that it would reduce competition in the litigation funding market by creating barriers to entry and regulatory risk for new, or less specialised, litigation funders," urging policymakers to weigh the benefits against "an increase in pricing."

Looking ahead, Haughan said he expects continued growth in securities litigation and "some consolidation in the market within the next five years." He added that an opt-out consumer class actions regime "would materially increase our appetite to invest in product liability and environmental claims in the UK."

On control, he said Woodsford has the right to be kept informed, but "the claimants have authority over the settlement."